Soluble FLT1 Gene Therapy Alleviates Brain Arteriovenous Malformation Severity

BACKGROUND AND PURPOSE: Brain arteriovenous malformation (bAVM) is an important risk factor for intracranial hemorrhage. Current therapies are associated with high morbidities. Excessive vascular endothelial growth factor (VEGF) has been implicated in bAVM pathophysiology. Because soluble FLT1 binds...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Stroke
Asıl Yazarlar: Zhu, Wan, Shen, Fanxia, Mao, Lei, Zhan, Lei, Kang, Shuai, Sun, Zhengda, Nelson, Jeffrey, Zhang, Rui, Zou, Dingquan, McDougall, Cameron M., Lawton, Michael T., Vu, Thiennu H., Wu, Zhijian, Scaria, Abraham, Colosi, Peter, Forsayeth, John, Su, Hua
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5404983/
https://ncbi.nlm.nih.gov/pubmed/28325846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.116.015713
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller